Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles
04:32pm, Tuesday, 29'th Apr 2025
Live Updates Live Coverage Has Ended S&P 500 Extends Its Winning Streak 4:18 pm The S&P 500 closed up 0.6% for Tuesday, extending its winning streak to six straight days. Trade Talks Keep S&am
Why Novo Nordisk Stock Is Soaring Today
04:01pm, Tuesday, 29'th Apr 2025
Shares of Novo Nordisk (NVO 3.94%) are up on Tuesday. The company's stock gained 3.9% as of 2:40 p.m.
Growth Is Priced Out Of Novo Nordisk
02:29pm, Tuesday, 29'th Apr 2025
A lot went wrong for Novo Nordisk A/S in the last six months, and a lot went right for competitor Eli Lilly. Novo Nordisk's competitive positioning in the obesity market has worsened, but I believe th
Hims & Hers stock pops on Novo Nordisk partnership
12:36pm, Tuesday, 29'th Apr 2025
Hims & Hers (NYSE:HIMS) shares surged after it announced a partnership with Novo Nordisk that will allow it to offer the drugmaker's weight loss product Wegovy through its telehealth platform. Investo
Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform
12:13pm, Tuesday, 29'th Apr 2025
Novo Nordisk A/S NVO and Hims & Hers Health, Inc. HIMS announced a long-term collaboration on Tuesday.
Pharma firms maastraz
12:06pm, Tuesday, 29'th Apr 2025
Jimmy Muchechetere, senior equity analyst at Investec, weighs in on the prospect of pharmaceutical tariffs and recent U.S. investment commitments from the sector.
Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?
11:20am, Tuesday, 29'th Apr 2025
NVO's first-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially Wegovy, Ozempic and Rybelsus.
Hims & Hers partners with Novo Nordisk to sell Wegovy
11:20am, Tuesday, 29'th Apr 2025
Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on its telehealth platform.
Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback
10:30am, Tuesday, 29'th Apr 2025
Hims & Hers Health, Inc. just announced a partnership with Novo Nordisk, Ro and LifeMD to sell their Wegovy at a discounted price. The deal is a game changer, enabling Hims to offer Wegovy at $599/mon
White House Slams AMZN, HIMS & NVO Wegovy Partnership, SOFI Rallies
10:30am, Tuesday, 29'th Apr 2025
Amazon (AMZN) shares faced selling pressure after the White House called the company's decision to display tariff costs on products a "hostile and political act." Diane King Hall notes it's just the l
Hims & Hers pact with Novo de-risks 2025 outlook, says Needham
10:03am, Tuesday, 29'th Apr 2025
Hims & Hers +7.43 (+26.06%) Novo Nordisk +1.96 (+3.13%) 05 May 07 May 12 Jun
Hims & Hers to Sell Novo Nordisk's Wegovy in U.S., Shares Soar
09:23am, Tuesday, 29'th Apr 2025
Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.
Hims & Hers Stock Soars 45%. Why a Deal With Novo Nordisk for Weight-Loss Drugs Matters.
08:07am, Tuesday, 29'th Apr 2025
The companies announced a long-term collaboration to make obesity treatments more affordable, they said on Tuesday.
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
07:52am, Tuesday, 29'th Apr 2025
Novo Nordisk said it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health, Ro and Life MD. The Danish drugmaker is racing to capture more patients now that many com
Hims & Hers partners with Novo Nordisk to sell Wegovy on its platform
07:44am, Tuesday, 29'th Apr 2025
Danish drugmaker Novo Nordisk has partnered with Hims & Hers Health's to sell its popular weight loss drug through a bundled offering on the telehealth company's platform, the two companies said on Tu
